Dr. Ilan Shapira, MD

Dr. Shapira practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Shapira's NPI, 1649253675, was assigned on November 23, 2005. Dr. Shapira holds New York license 226789.

Dr. Shapira's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Shapira's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Shapira is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Shapira to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shapira practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shapira's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shapira is licensed in New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lymphoma, multiple myeloma, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Shapira treats.

CMS data shows 815 Medicare services from Dr. Shapira across 6 procedure codes in 2024, for 258 Medicare patients. Medicare paid $62,000 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Dr. Shapira in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shapira's median patient age at 68, with 55% women.

In 2024, Dr. Shapira wrote 1,253 Medicare Part D claims for 157 patients. 56% of them were for generic drugs. CMS names the drug for 1,050 of them, across 29 drugs with 11 or more claims each, at $6,208,693 in total drug cost. In 2023, CMS named 876 claims across 25 drugs.

Dr. Shapira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shapira as offering telehealth.

Dmand AI links 12 papers to Dr. Shapira, published from 2012 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Shapira has published most often in Case Rep Hematol. Dr. Shapira's most frequent co-authors are Kenneth Lee Angelino, MD, Richard L. Bakst, MD and Eva Elaine Berlin.

Dmand AI links Dr. Shapira to 1 clinical trial. Conditions studied include Purpura, Thrombotic Thrombocytopenic and Thrombophilia.

CMS Open Payments shows 1,042 general payments to Dr. Shapira from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Alexion Pharmaceuticals, Inc. paid the most, $167,939.

Dr. Shapira is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.